Global trial of PTG-300 in patients with beta-thalassemia
Phase of Trial: Phase III
Latest Information Update: 07 Mar 2018
At a glance
- Drugs PTG 300 (Primary)
- Indications Beta-thalassaemia
- Focus Therapeutic Use
- 07 Mar 2018 According to a Protagonist Therapeutics media release, the company is planning to initiate this trial in the second half of 2018.
- 06 Mar 2018 According to a Protagonist Therapeutics media release, the company intends to initiate this trial after upcoming meetings with the U.S. and European regulatory agencies.
- 20 Dec 2017 New trial record